Search - tctmd.com

Displaying 61 - 80 of 4083

Sort: Relevancy | Date

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

Presentation TCT 2025

Management of BPA Complications

Presenter: Kenneth Rosenfield

October 27, 2025

Presentation TCT 2025

BPA Masterclass: Getting from Good to Great

Presenter: Hiromi Matsubara

October 27, 2025

Presentation TCT 2025

How to Start a BPA program - What are the Nuts and Bolts of the Procedure?

Presenter: Vikas Aggarwal

October 27, 2025

Presentation TCT 2025

Who Gets Drugs, Intervention, and/or Surgery? The Role of a CTEPH Team

Presenter: John Gerry Coghlan

October 27, 2025

Presentation TCT 2025

I Suspect CTEPH: How to Interpret RHC Findings and How to Get the Best Pulmonary Angiogram Possible

Presenter: Vladimir Lakhter

October 27, 2025

Presentation TCT 2025

My Patient Has Had a PE. Should I Screen Them for CTEPH and if so, How?

Presenter: Estefania Oliveros

October 27, 2025

Presentation TCT 2025

TCT 1904: Endovascular Repair of an Infrarenal Abdominal Aortic Aneurysm With Aortoenteric Fistula: A Rare Clinical Presentation

Presenter: Aakash Batra

October 27, 2025

Presentation TCT 2025

What Should the New Guidelines Say?

Presenter: Stavros Konstantinides

October 27, 2025

Presentation TCT 2025

Adjusting PE interventions for Vulnerable Populations

Presenter: Sanjum S. Sethi

October 27, 2025

Presentation TCT 2025

TCT 1922: Successful Endovascular Treatment for MTB Infection Related Mycotic Subclavian Artery Aneurysm After Intravesical BCG Treatment for Bladder Malignancy

Presenter: Jae Young Jeung

October 27, 2025

Presentation TCT 2025

Mitigating Complications in Catheter Interventions: What Can New Devices Offer?

Presenter: John Moriarty

October 27, 2025

Presentation TCT 2025

Up to 50% of Patients Have the Post-PE Syndrome - Could Catheters Help?

Presenter: Eric A. Secemsky

October 27, 2025

Presentation TCT 2025

In Intermediate-risk PE, What Measurable Improvements Can Catheter-Based Therapy Offer Over Anticoagulation??

Presenter: Suhail Dohad

October 27, 2025

Presentation TCT 2025

What can CDT Accomplish that MT Can’t Do Faster?

Presenter: Michael Young

October 27, 2025

Presentation TCT 2025

Initial, Prospective Analysis of Uncontrolled Hypertensive Patients Included in the Global Paradise System (GPS) Registry Outside of the United States

Presenter: Karl Fengler

October 27, 2025

Presentation TCT 2025

First Report of the SPYRAL AFFIRM Study: Reduced Home and Office Blood Pressure Following Radiofrequency Renal Denervation in a Large US Cohort of High Cardiovascular Risk Patients.

Presenter: Felix Mahfoud

October 27, 2025

Presentation TCT 2025

Pipeline Devices for HTN

Presenter: Lucas Lauder

October 27, 2025

Presentation TCT 2025

On-Table Predictors of Successful Denervation - Where are We in 2025?

Presenter: Felix Mahfoud

October 27, 2025

Presentation TCT 2025

Renal Denervation is FDA Approved - Will it Ever Be First Line Therapy?

Presenter: David P. Lee

October 27, 2025

Advertisement

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

Management of BPA Complications

BPA Masterclass: Getting from Good to Great

How to Start a BPA program - What are the Nuts and Bolts of the Procedure?

Who Gets Drugs, Intervention, and/or Surgery? The Role of a CTEPH Team

I Suspect CTEPH: How to Interpret RHC Findings and How to Get the Best Pulmonary Angiogram Possible

My Patient Has Had a PE. Should I Screen Them for CTEPH and if so, How?

TCT 1904: Endovascular Repair of an Infrarenal Abdominal Aortic Aneurysm With Aortoenteric Fistula: A Rare Clinical Presentation

What Should the New Guidelines Say?

Adjusting PE interventions for Vulnerable Populations

TCT 1922: Successful Endovascular Treatment for MTB Infection Related Mycotic Subclavian Artery Aneurysm After Intravesical BCG Treatment for Bladder Malignancy

Mitigating Complications in Catheter Interventions: What Can New Devices Offer?

Up to 50% of Patients Have the Post-PE Syndrome - Could Catheters Help?

In Intermediate-risk PE, What Measurable Improvements Can Catheter-Based Therapy Offer Over Anticoagulation??

What can CDT Accomplish that MT Can’t Do Faster?

Initial, Prospective Analysis of Uncontrolled Hypertensive Patients Included in the Global Paradise System (GPS) Registry Outside of the United States

First Report of the SPYRAL AFFIRM Study: Reduced Home and Office Blood Pressure Following Radiofrequency Renal Denervation in a Large US Cohort of High Cardiovascular Risk Patients.

Pipeline Devices for HTN

On-Table Predictors of Successful Denervation - Where are We in 2025?

Renal Denervation is FDA Approved - Will it Ever Be First Line Therapy?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content